Axolotl™

Axolotl DualGraft™ is dehydrated human amnion membrane allograft derived from the amniotic lining of the placenta. Axolotl DualGraft™ is indicated as a wound covering and structural barrier.

Axolotl™ graft product is processed through minimal manipulation techniques, retaining the native qualities of the amniotic membrane to function as a wound covering and as a structural barrier.

Axolotl DualGraft™ is marketed under Section 361 of the PHS act and regulated under 21 CFR Part 1271.

Axolotl™ graft product have received a letter of recommendation from the FDA Tissue Reference Group (TRG) and are manufactured in an AATB accredited manufacturing environment.